Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-018342
Filing Date
2025-05-23
Accepted
2025-05-23 16:12:37
Documents
3
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 4110
2 crvo20250523_sec16.htm EX-24 8640
3 ekstamp01.jpg GRAPHIC 10965
  Complete submission text file 0001437749-25-018342.txt   29693
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AURA BIOSCIENCES, INC. 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address
De Rosch Mark (Reporting) CIK: 0001890320 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 25982353